Media Releases

Tactile Systems Technology, Inc. Reports First Quarter 2017 Financial Results; Updates 2017 Outlook

May 17, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices that treat lymphedema and chronic venous insufficiency, today announced its Flexitouch® system will be available throughout the United States to treat lymphedema of the head and neck, a common consequence of head and neck cancer and related treatment, making it the first and only pneumatic compression therapy approved for this condition.

See full release >

Tactile Systems Technology, Inc. Reports First Quarter 2017 Financial Results; Updates 2017 Outlook

May 8, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices for the treatment of lymphedema and chronic venous insufficiency, today reported financial results for the first quarter ended March 31, 2017.

See full release > >

Tactile Medical to Release First Quarter 2017 Financial Results on May 8, 2017

April 10, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today announced that first quarter 2017 financial results will be released after the market closes on Monday, May 8.

See full release > >

Tactile Systems Technology, Inc. Reports Fourth Quarter and Full Year 2016 Financial Results; Provides 2017 Outlook

February 27, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported financial results for the fourth quarter and year ended December 31, 2016. 

See full release > >

Tactile Medical to Release Fourth Quarter and Fiscal Year 2016 Financial Results on February 27th

February 14, 2017

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today announced that fourth quarter and fiscal year 2016 financial results will be released after the market closes on February 27th.

See full release > >

Tactile Medical to Ring the Nasdaq Stock Market Opening Bell

January 17, 2017

Tactile Systems Technology Inc. (“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices that treat lymphedema and venous ulcers, will celebrate its 2016 initial public offering (“IPO”) by ringing the Nasdaq Stock Market opening bell in New York City on Tuesday, January 17. The Company began trading on the Nasdaq Global Market on July 28, 2016.

See full release > >

Tactile Systems Technology, Inc. Reports Third Quarter 2016 Financial Results and Updates Fiscal Year 2016 Outlook

November 10, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported financial results for the third quarter and nine months ended September 30, 2016.

See full release > >

Tactile Medical Receives FDA 510(k) Clearance for New Indication of At-Home Lymphedema Treatment

September 22, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, announced today that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the Flexitouch System in treating lymphedema of the head and neck, a common consequence of head and neck cancer.

See full release > >

Tactile Systems Technology, Inc. Reports Second Quarter 2016 Financial Results and Introduces Fiscal Year 2016 Outlook; Q2 Revenue Increased 34% Year-over-Year

September 7, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops and provides innovative medical devices for the treatment of chronic diseases at home, today reported financial results for the second quarter ended June 30, 2016.

See full release > >

Tactile Systems Announces Closing of Initial Public Offering

August 2, 2016

Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a medical technology company that develops innovative medical devices for the treatment of chronic diseases at home, announced the closing of its initial public offering on August 2nd, 2016 of 4,120,000 shares of common stock at a public offering price of $10.00 per share, before underwriting discounts and commissions.

See full release >

Tactile Systems Announces Pricing of Initial Public Offering

July 27, 2016

Tactile Systems Technology, Inc. (“Tactile”) (Nasdaq:TCMD), a medical technology company that develops innovative medical devices for the treatment of chronic diseases at home, announced the pricing of its initial public offering July 27th, 2016, of 4,000,000 shares of common stock at a public offering price of $10.00 per share.

See full release >

Tactile Medical Named to Top Workplaces for Seventh Consecutive Year

June 27, 2016

For the seventh consecutive year, Tactile Medical was recognized as a Top Workplace by the Star Tribune. Employees from 1,556 companies were surveyed and Tactile Medical ranked 15 among midsize companies, a marked increase from its 2015 rank of 63 among small firms.

See full release >

Groundbreaking Research Changes Outlook for Lymphedema Patients

Oct. 7, 2015

Pneumatic compression device shown to provide major clinical benefit, while lowering the overall cost of care

Patients who used a Flexitouch device reduced their overall healthcare utilization (defined by decreased outpatient clinic, inpatient hospital, and physical therapy visits), which lowered their healthcare costs.

See full release >

Darren Wennen Joins Tactile Medical as Vice President of Marketing

Feb. 10, 2014

Industry Veteran to Lead Medical Device Company’s Next Growth Phase

Tactile Medical Inc., a Minneapolis-based medical device company focused on advancing the treatment of chronically ill patients in their homes, is expanding its senior management team as it continues to enter new markets and broaden its product portfolio.

See full release >

Net Health Announces Collaboration with Tactile Medical to Provide Pneumatic Compression Solutions

February 3, 2014

Net Health, the leader in software solutions for outpatient specialty care, is pleased to announce its clients can now order Flexitouch® and ACTitouch products from Tactile Medical electronically through the WoundExpert software, the nation’s leading software solution for wound care.

See full release >

Tactile Medical Launches New Wound Care Product to Treat Venous Leg Ulcers

Sept. 5, 2013

Tactile Medical (formerly Tactile Systems Technology Inc.), a Minneapolis–based developer and provider of home therapy devices, launched a first–of–its–kind ambulatory device for patients with chronic wounds.

See full release >

Star Tribune names Tactile Systems Technology, Inc. to Star Tribune’s Top Workplaces 2013

June 17, 2013

Tactile Systems Technology, Inc. has been named for the fourth consecutive year, one of the Top 100 Workplaces in Minnesota based on an employee-based survey project from the Star Tribune.

See full release >

Tactile Systems Technology Appoints New Board Chair, Expands Medical Leadership

Jan 3, 2013

Tactile Systems Technology Inc., a Minneapolis–based developer of chronic swelling and vascular disease therapies, is adding veteran leadership and top medical talent as it prepares to enter new markets and broaden its treatment portfolio. The appointments include a new chairman of the board of directors, a scientific advisory board and a chief medical officer.

See full release >

Tactile Systems Technology Announces Financing from Radius Ventures

Oct 4, 2012

Tactile Systems Technology Inc., currently a leading provider of at–home lymphedema treatment, today announced it has secured $10.4 million of Series–B financing led by Radius Ventures. Galen Partners also participated in the round of financing.

See full release >